# Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients

> **NCT01448499** · NA · WITHDRAWN · sponsor: **Geha Mental Health Center**

## Conditions studied

- Schizophrenia
- Treatment Resistant Disorders

## Interventions

- **DRUG:** Clozapine
- **DRUG:** Amisulpride
- **DRUG:** Clozapine+Amisulpride

## Key facts

- **NCT ID:** NCT01448499
- **Lead sponsor:** Geha Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-10
- **Primary completion:** 2013-10
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448499, "Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01448499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*